Language:

Results 21 - 40 of 1,560,665 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

1 Results 2 3 4 5

Show only

Peer-reviewed Journals (1,253,399)

Result Number	Material Type	Record Details and Options
21	Material Type: Article	Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy Journal of hematology and oncology, 2019-05, Vol.12 (1), p.54-54, Article 54 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0738-1 ;PMID: 31151482 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
22	Material Type: Article	EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5675-4 ;PMID: 31126258 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
23	Material Type: Article	Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT Molecular cancer, 2019-03, Vol.18 (1), p.40-40, Article 40 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0959-5 ;PMID: 30866952 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
24	Material Type: Article	TIM-3, a promising target for cancer immunotherapy OncoTargets and therapy, 2018-01, Vol.11, p.7005-7009 [Peer Reviewed Journal] COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 He et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1178-6930 ;EISSN: 1178-6930 ;DOI: 10.2147/ott.s170385 ;PMID: 30410357 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
25	Material Type: Article	Correction to: The function and mechanisms of action of circular RNAs in Urologic Cancer Molecular cancer, 2023-04, Vol.22 (1), p.73-73, Article 73 [Peer Reviewed Journal] COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-023-01774-2 ;PMID: 37095498 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
26	Material Type: Article	Effect of CCR2-V64I on the Susceptibility of Patients to Cancer European journal of cancer care, 2023-06, Vol.2023, p.1-10 [Peer Reviewed Journal] Copyright © 2023 Xue-Jiao Lu et al. ;COPYRIGHT 2023 Hindawi Limited ;Copyright © 2023 Xue-Jiao Lu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;ISSN: 1365-2354 ;ISSN: 0961-5423 ;EISSN: 1365-2354 ;DOI: 10.1155/2023/7630422 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
27	Material Type: Article	Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway Molecular cancer, 2019-02, Vol.18 (1), p.20-20, Article 20 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-018-0935-5 ;PMID: 30717751 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
28	Material Type: Article	Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer Molecular cancer, 2019-03, Vol.18 (1), p.68-68, Article 68 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0972-8 ;PMID: 30927911 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
29	Material Type: Article	Exosome-based immunotherapy: a promising approach for cancer treatment Molecular cancer, 2020-11, Vol.19 (1), p.1-160, Article 160 [Peer Reviewed Journal] COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-020-01278-3 ;PMID: 33183286 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
30	Material Type: Article	The growing cancer burden Bulletin of the World Health Organization, 2024-03, Vol.102 (3), p.152 [Peer Reviewed Journal] COPYRIGHT 2024 World Health Organization ;ISSN: 0042-9686 ;EISSN: 1564-0604 ;DOI: 10.2471/BLT.24.010324 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
31	Material Type: Article	Cancer increasing Bulletin of the World Health Organization, 2024-03, Vol.102 (3), p.152 [Peer Reviewed Journal] COPYRIGHT 2024 World Health Organization ;ISSN: 0042-9686 ;EISSN: 1564-0604 ;DOI: 10.2471/BLT.24.010324 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
32	Material Type: Article	Correction to: FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1 Oncogene, 2021-04, Vol.40 (16), p.2998-3000 [Peer Reviewed Journal] COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature Limited 2021. ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/s41388-021-01751-3 ;PMID: 33767442 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
33	Material Type: Article	Classification of circulating tumor cells by epithelial-mesenchymal transition markers PloS one, 2015-04, Vol.10 (4), p.e0123976-e0123976 [Peer Reviewed Journal] COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Wu et al 2015 Wu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0123976 ;PMID: 25909322 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
34	Material Type: Article	Finding Quality in Cancer Care Beyond the Hospital Walls The American journal of managed care, 2023-02 [Peer Reviewed Journal] COPYRIGHT 2023 Intellisphere, LLC ;ISSN: 1088-0224 ;EISSN: 1936-2692 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
35	Material Type: Book	Molecular Features Distinguishing Gastric Cancer Subtypes https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode ;ISBN: 9783038974055 ;ISBN: 3038974056 ;ISBN: 3038974048 ;ISBN: 9783038974048 ;DOI: 10.3390/books978-3-03897-405-5 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
36	Material Type: Article	Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis BMC cancer, 2019-06, Vol.19 (1), p.589-589, Article 589 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5791-1 ;PMID: 31208348 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
37	Material Type: Article	Second Primary Cancers following Colorectal Cancer in Sicily, Italy Cancers, 2022-10, Vol.14 (21), p.5204 [Peer Reviewed Journal] COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers14215204 ;PMID: 36358623 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
38	Material Type: Article	Correction: HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3 BMC cancer, 2022-04, Vol.22 (1), p.467-467, Article 467 [Peer Reviewed Journal] COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09579-0 ;PMID: 35484582 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
39	Material Type: Article	Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models Journal of experimental & clinical cancer research, 2023-08, Vol.42 (1), p.1-211, Article 211 [Peer Reviewed Journal] COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Italian National Cancer Institute ‘Regina Elena’ 2023 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-023-02797-9 ;PMID: 37596687 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
40	Material Type: Article	Plasma free amino acid profiling of five types of cancer patients and its application for early detection PloS one, 2011-09, Vol.6 (9), p.e24143-e24143 [Peer Reviewed Journal] COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Miyagi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Miyagi et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0024143 ;PMID: 21915291 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by